Document is current

Any future updates will be listed below

Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia

Crossref DOI link: https://doi.org/10.1007/s00520-014-2582-8

Published Online: 2015-01-10

Published Print: 2015-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark